Active, Not Recruiting Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC NCT04413123 Conditions Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +21 more Locations Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States Brigham & Woman's Hospital — Boston, Massachusetts, United States Dana Farber Cancer Institute — Boston, Massachusetts, United States UT Southwestern Medical — Dallas, Texas, United States View Trial Details
